Atlas Trials

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Clinical trial NCT01641393 · COMPLETED

Trial details

NCT number
NCT01641393
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Exocrine Pancreatic Insufficiency: Cystic Fibrosis
Start date
2012-06-01
Primary completion
2014-02-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.